Add this topic to your myFT Digest for news straight to your inbox
Speculation grows that company will sell prescription medicines and drive down prices
Welcome to Due Diligence, the FT’s daily deals briefing
Drugstore chain will instead buy more than 2,000 stores for $5.2bn
Executive instrumental in acquisition of UK chain and its later merger with Walgreens
A company only takes a deal price cut when it has little leverage
The 75-year-old billionaire still wants to build a presence in China
Nasdaq-listed company Walgreens Boots Alliance agrees franchise deal selling products for local tastes
Change at UK’s largest pharmacy chain comes amid reshuffle at US parent
New chief executive will consider pulling the plug on unprofitable agreement within months
Pharmacy chain exposed to fortunes of sector’s most contentious names
Pharmacy chain weighs whether it can terminate its contract with the blood-testing start-up
International Edition